ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 148 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $272,000 | -20.9% | 4,415 | -27.4% | 0.00% | 0.0% |
| Q3 2018 | $344,000 | +4.6% | 6,082 | +23.5% | 0.00% | 0.0% |
| Q2 2018 | $329,000 | -87.1% | 4,925 | -88.8% | 0.00% | -66.7% |
| Q1 2018 | $2,555,000 | -9.3% | 43,890 | +0.5% | 0.01% | -14.3% |
| Q4 2017 | $2,817,000 | +2.5% | 43,691 | -16.6% | 0.01% | +16.7% |
| Q3 2017 | $2,748,000 | +12.2% | 52,366 | -0.0% | 0.01% | 0.0% |
| Q2 2017 | $2,450,000 | -10.5% | 52,389 | -5.2% | 0.01% | -14.3% |
| Q1 2017 | $2,737,000 | -12.2% | 55,288 | +7.5% | 0.01% | -22.2% |
| Q4 2016 | $3,117,000 | +141.1% | 51,415 | +163.9% | 0.01% | +125.0% |
| Q3 2016 | $1,293,000 | +7.3% | 19,480 | -9.8% | 0.00% | 0.0% |
| Q2 2016 | $1,205,000 | +1.9% | 21,594 | -17.6% | 0.00% | +33.3% |
| Q4 2015 | $1,183,000 | -47.3% | 26,198 | -59.8% | 0.00% | -50.0% |
| Q2 2014 | $2,246,000 | – | 65,222 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |